![]() | Up a level |
Abolhasani, Shiva and Hejazian, Seyyed Sina and Karpisheh, Vahid and Khodakarami, Atefeh and Mohammadi, Hamed and Gholizadeh Navashenaq, Jamshid and Hojjat-Farsangi, Mohammad and Jadidi-Niaragh, Farhad (2022) The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia. IUBMB Life. ISSN 1521-6543
Barshidi, Asal and Karpisheh, Vahid and Karimian Noukabadi, Fatemeh and Mohammadi, Mohammad and Karoon Kiani, Fariba and Afsharimanesh, Negin and Ebrahimi, Farbod and Kiaie, Seyed Hossein and Gholizadeh Navashenaq, Jamshid and Hojjat-Farsangi, Mohammad and Majidi Zolbanin, Naime and Mahmoodpoor, Ata and Hassannia, Hadi and Nami, Sanam and Jalali, Pooya and Jafari, Reza and Jadidi-Niaragh, Farhad (2022) Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. Pharmaceutical Research. ISSN 0724-8741
Khodakarami, Atefeh and Adibfar, Sara and Karpisheh, Vahid and Abolhasani, Shiva and Jalali, Pooya and Mohammadi, Hamed and Gholizadeh Navashenaq, Jamshid and Farsangi, Mohammad Hojjat and Jadidi-Niaragh, Farhad (2022) The molecular biology and therapeutic potential of Nrf2 in leukemia. Cancer Cell International, 241. ISSN 1475-2867
Hojjat-Farsangi, Mohammad and Ghalamfarsa, Ghasem and Kazemi, Mohammad Hossein and Raoofi Mohseni, Sahar and Masjedi, Ali and Azizi, Gholamreza and Yousefi, Mehdi and Jadidi-Niaragh, Farhad (2019) CD73 as a potential opportunity for cancer immunotherapy. Expert Opinion on Therapeutic Targets, 23 (2). pp. 127-142.
Hojjat-Farsangi, Mohammad and Hosseini, Arefeh and Masjedi, Abdolrahim and BARADARAN, B and Ghalamfarsa, Ghasem and Anvari, Enayat and Jadidi-Niaragh, Farhad (2019) Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis. Journal of Cellular Physiology, 234 (7). pp. 9943-9955.
Hojjat-Farsangi, Mohammad and Bahrami, Behdokht and Mohammadi, Hamed and Anvari, Enayat and Ghalamfarsa, Ghasem and Yousefi, Mehdi and Jadidi-Niaragh, Farhad (2017) Nanoparticles and targeted drug delivery in cancer therapy. Immunology Letters, 190. pp. 64-83.